Geographic Atrophy

Pegcetacoplan slows GA lesion growth with increasing effects over time

Data presented at AAO 2022 demonstrated that monthly and every-other-month (EOM) treatment with pegcetacoplan preserved visual function of retinal cells near the geographic atrophy (GA) lesion border. In the phase 3 OAKS study of the investigational targeted C3 therapy, patients treated with monthly or EOM pegcetacoplan loss less retinal sensitivity...